1357: Treatment Choice in Relation to the Patient's Risk Profile in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: A Systematic Analysis of Expert Opinion
Michael P. O’Leary(University of California, Irvine), Herman Stoevelaar(Barnes-Jewish Hospital), Giario Conti, José E. Batista(Fundación Teknon), Franklin C. Lowe(St. Luke's-Roosevelt Hospital Center), K. Dreikorn, Emmanuel Chartier‐Kastler(Sorbonne Université)
Cited by 1
Related Papers
International Continence Society best practice statement for use of sacral neuromodulation
|Neurourology and Urodynamics|2018|173
The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel
|Annals of the Rheumatic Diseases|2010|105
Appropriate referral and selection of patients with chronic pain for spinal cord stimulation: European consensus recommendations and e‐health tool
|European Journal of Pain|2020|95
Sexual function before and after various treatments for symptomatic benign prostatic hyperplasia
|British Journal of Urology|2002|94
A decision tool to support appropriate referral for deep brain stimulation in Parkinson’s disease
|Journal of Neurology|2009|55